✦ LIBER ✦

NSAID use and breast cancer risk in the VITAL cohort

✍ Scribed by Ann Ready; Christine M. Velicer; Anne McTiernan; Emily White

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 164 KB
Volume: 109
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9665-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NSAIDs and breast cancer recurrence in a

NSAIDs and breast cancer recurrence in a prospective cohort study

✍ Marilyn L. Kwan; Laurel A. Habel; Martha L. Slattery; Bette Caan 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 141 KB

Use of glucosamine and chondroitin and l

Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort

✍ Theodore M. Brasky; Johanna W. Lampe; Christopher G. Slatore; Emily White 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 189 KB

Non-steroidal anti-inflammatory drug (NS

Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study

✍ Theodore M. Brasky; Matthew R. Bonner; Kirsten B. Moysich; Christine B. Ambroson 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 202 KB

Hypertension, antihypertensive medicatio

Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort

✍ Joan A. Largent; Leslie Bernstein; Pamela L. Horn-Ross; Sarah F. Marshall; Susan 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 188 KB

Association between NSAIDs use and breas

Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis

✍ Ya-shuang Zhao; Sui Zhu; Xiang-wei Li; Fan Wang; Fu-lan Hu; Dan-dan Li; Wen-cui 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 262 KB

Postmenopausal hormone therapy and breas

Postmenopausal hormone therapy and breast cancer risk: The multiethnic cohort

✍ Sulggi Lee; Laurence Kolonel; Lynne Wilkens; Peggy Wan; Brian Henderson; Malcolm 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 95 KB 👁 2 views

## Abstract Epidemiological studies indicate that menopausal estrogen‐progestin therapy (EPT) use is associated with an increase in breast cancer risk. Further data are needed on whether this association varies by specific prognostic factors and ethnicity. We conducted a cohort study among 55,371 A